Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Minority Interest (2019 - 2025)

Sanara MedTech's Minority Interest history spans 7 years, with the latest figure at -$8666.0 for Q4 2025.

  • For Q4 2025, Minority Interest rose 98.24% year-over-year to -$8666.0; the TTM value through Dec 2025 reached -$8666.0, up 98.24%, while the annual FY2025 figure was -$8666.0, 98.24% up from the prior year.
  • Minority Interest reached -$8666.0 in Q4 2025 per SMTI's latest filing, down from -$8422.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of -$3431.0 in Q1 2025 to a low of -$809520.0 in Q3 2022.
  • Average Minority Interest over 5 years is -$317010.8, with a median of -$291713.0 recorded in 2024.
  • Peak YoY movement for Minority Interest: tumbled 127.1% in 2023, then skyrocketed 98.77% in 2025.
  • A 5-year view of Minority Interest shows it stood at -$488397.0 in 2021, then skyrocketed by 77.98% to -$107555.0 in 2022, then tumbled by 127.1% to -$244260.0 in 2023, then plummeted by 101.27% to -$491611.0 in 2024, then skyrocketed by 98.24% to -$8666.0 in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Minority Interest are -$8666.0 (Q4 2025), -$8422.0 (Q3 2025), and -$7467.0 (Q2 2025).